Tacrolimus (FK506) Cerebral Blindness Following Translplantation

Update Item Information
Identifier 19950220_nanos_sciplatform2_04
Title Tacrolimus (FK506) Cerebral Blindness Following Translplantation
Creator Todd C. Geis, MD; Nancy J. Newman, MD
Affiliation Atlanta, Georgia
Subject Tacrolimus; FK506; Cerebral Blindness; Transplant Surgery; Neurotoxicity
Description Tacrolimus (FK506) is an immunosuppressant agent in use since 1984 to prevent graft rejection following transplantation. It is presumed similar to cyclosporine in its mode of action and its toxicity. Neurotoxicity secondary to FK506 has been described and may be more common than with cyclosporins.
Date 1995-02-21
Language eng
Format application/pdf
Type Text
Source 1995 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 1995: Science Platform Presentations (Session II)
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 1995. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6hx4k92
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Setname ehsl_novel_nam
ID 182672
Reference URL https://collections.lib.utah.edu/ark:/87278/s6hx4k92
Back to Search Results